Marc Lemonnier
@MLantabio
Followers
485
Following
963
Media
20
Statuses
1K
Founding CEO of @antabio, a European biotech fighting #AMR; SAB member at @JPIAMR. Lead at ARPEGE_AMR
Joined November 2010
RT @valeria_gigante: ⚡️ Great panel on the value of antibiotics. We need ABs able to address the highest unmet medical needs and strong tra….
0
2
0
RT @B3Cnewswire: ANTABIO Raises €25 million in Series B Financing. The financing will be used to support the clinical development of MEM-AN….
0
1
0
RT @CIDRAP: French drugmaker receives funding for combination antibiotic. Antabio announced that it raised $25 million in financing to comp….
cidrap.umn.edu
Antabio announced that it raised $25 million in financing to complete phase 2 research on its antibiotic/beta-lactamase inhibitor combination.
0
3
0
RT @AMRActionFund: We are thrilled to welcome @antabio to our portfolio. Learn more about the company's €25 million Series B round: https:/….
0
4
0
RT @LaTribuneTlse: #Toulouse - #Santé : Antabio boucle une série B majeure pour commercialiser son premier traitement .
0
4
0
RT @maxletex: @capus_samuel @bleucitron_tour @Pictarine Intervention ensuite inspirante de Marc Lemonnier de @antabio sur une idée séduisan….
0
1
0
Très peiné par cette nouvelle. P-O G était toujours prêt à aider les biotechs françaises, toujours à l'écoute. Au nom d'@antabio, condoléances à sa famille et à ses proches.
Sous le choc du décès de Pierre-Olivier Goineau, j’adresse toutes mes condoléances à sa famille, ses proches et à ses amis. J’ai côtoyé plusieurs années POG au sein du CA de @FranceBiotech, c’était une belle personnalité, bienveillante et attachante, repose en paix POG. 🕊️
0
0
0
The start of our first in man study for MEM-ANT3310 marks a significant milestone for @antabio as we transition to becoming a clinical stage biotechnology company. Today my warm gratitude goes to my colleagues at @antabio for their excellent work and continuous dedication. #AMR.
@antabio announces dosing of the first subjects in its Phase 1 clinical trial of MEM-ANT3310, a next generation treatment of hospital infections caused by carbapenem-resistant Acinetobacter baumannii (#CRAB) and carbapenem-resistant Enterobacterales (#CRE).
0
1
7
RT @ESCMID: Our first-place #ECCMID2023 Art Gallery winner is Ana Pelivan (Croatia) who won with her painting titled "Cause of Death" showc….
0
8
0
RT @antabio: Check our new paper on the chemical optimization & initial evaluation in cellular & animal models of @antabio's #Pseudomonas #….
0
12
0
RT @AllianceBEAM: 3⃣Revenues from new antimicrobials do not recoup R&D investments. As long as this equation is out of balance, it is impo….
0
3
0
RT @AllianceBEAM: 2⃣The biotech ecosystem is committed to developing new products, but #SMEs struggle to raise💰to fight #AMR.SMEs' survival….
0
4
0
RT @AllianceBEAM: Tomorrow kicks off #WAAW2022, so let's remember what's at stake. Next year will be critical in shaping tomorrow's innovat….
0
1
0
A pivotal report from our partners at #ARPEGE @TSEinfo on how Transferable Exclusivity Vouchers can be an effective mechanism for rewarding innovation and revitalizing the #AMR market. 👇.
A new policy paper by Pierre Dubois, Paul-Henri Moisson & #JeanTirole focused on the mechanisms & levers to be used to encourage innovation in the #AntimicrobialResistance sector. #ARPEGE_AMR.👉
0
0
0
RT @AllianceBEAM: BEAM signed a Call to Action to #G20 Leaders, Health and Finance Ministers. Take a look at the recommendations focusing o….
h20annualsummit.com
Health 20 - A CALL TO ACTION to G20 Leaders, Health and Finance Ministers ahead of the G20 Summit in September.
0
2
0
RT @AllianceBEAM: Great discussion today at the scientific symposium organized in the frame of the @Europe2022FR and dedicated to #antimicr….
0
3
0
RT @AllianceBEAM: The #EU Pharma Legislation revision is on the horizon. What solutions do #SMEs need from our policymakers to unlock the i….
0
9
0
RT @AllianceBEAM: 4 Pillars in Focus: 80% of the global AMR product pipeline is held by SMEs. In order to #2 unlock the innovation potentia….
0
2
0